A simple method for quantifying Leishmania in tissues of infected animals.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Parasitology Today

• Publication date

  1997-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0169-4758(96)40010-2PMID 15275128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease.

  1995cited by this paper
• T cell and non-T cell compartments can independently determine resistance to Leishmania major

  1995cited by this paper
• The effect of treating with anti‐interleukin‐1 receptor antibody on the course of experimental murine cutaneous leishmaniasis

  1994cited by this paper
• Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse.

  1994cited by this paper
• Macrophage-Pathogen Interactions

  1993cited by this paper
• Role of T cell subsets during the recall of immunologic memory to Leishmania major

  1992cited by this paper
• Is leishmaniasis ever cured?

  1992cited by this paper
• Human urine stimulates growth of Leishmania in vitro.

  1991cited by this paper
• Exacerbation of experimental murine cutaneous leishmaniasis with CD4+ Leishmania major‐specific T cell lines or clones which secrete interferon‐γ and mediate parasite‐specific delayed‐type hypersensitivity

  1991cited by this paper
• Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain.

  1989cited by this paper
• Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity.

  1988cited by this paper
• Visceral leishmaniasis recrudescence in a patient with AIDS.

  1987cited by this paper
• Visceral leishmaniasis recrudescence in a patient with AIDS

  1987cited by this paper
• A limiting dilution assay for quantifying Leishmania major in tissues of infected mice

  1985cited by this paper
• Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis

  1983cited by this paper
• Cell Separation: Methods and Selected Applications

  1983cited by this paper

• Fungal Biodiversity From the Atlantic Forest With Bioactive Metabolites Against Cutaneous Leishmaniasis

  2025cites this paper
• BALB/c mice infection with hybrid Leishmania (V.) guyanensis/L. (V.) shawi showed an intermediate virulence profile compared to parental species infections

  2025cites this paper
• Nanocrystallization Effectively Improves the Oral Efficacy of an Antileishmanial Chalcone

  2025cites this paper
• Impact of a previous infection with Taenia crassiceps cysticerci on the susceptibility to Leishmania (L.) major or L. (V.) braziliensis

  2025cites this paper
• Effect of Leishmania proteins in mice: Investigation of Leishmania amazonensis virulence molecules for therapy and prophylaxis of leishmaniasis

  2025cites this paper
• Leyşmaniya parazitlərinin müxtəlif qidalı mühitlərdə in vitro inkişafının müqayisəli öyrənilməsi

  2025cites this paper
• Bioactive Compounds with Leishmanicidal Potential from Helianthus tuberosus and Vernonanthura squamulosa

  2025influential citation
• Aspidosperma nitidum reduces parasite load and modulates cytokines in BALB/c mice infected with Leishmania (Leishmania) amazonensis

  2024cites this paper
• Attractiveness of golden hamster infected with Leishmania amazonensis (Kinetoplastida: Trypanosomatidae) to laboratory-reared Lutzomyia longipalpis (Diptera: Psychodidae).

  2024cites this paper
• Protective Humoral Immune Response Induced by Recombinant Virus-like Particle Vaccine Expressing Leishmania donovani Surface Antigen.

  2023cites this paper
• Persistent Cutaneous Leishmania major Infection Promotes Infection-Adapted Myelopoiesis

  2022cites this paper
• Eugenol derivatives with 1,2,3-triazole moieties: Oral treatment of cutaneous leishmaniasis and a quantitative structure-activity relationship model for their leishmanicidal activity.

  2022cites this paper
• Leishmania (L.) infantum chagasi isolated from skin lesions of patients affected by non-ulcerated cutaneous leishmaniasis lead to visceral lesion in hamsters.

  2022cites this paper
• In Vivo Safety and Efficacy of Chalcone-Loaded Microparticles with Modified Polymeric Matrix against Cutaneous Leishmaniasis

  2022cites this paper
• A Mouse Model of Ulcerative Cutaneous Leishmaniasis by Leishmania (Viannia) panamensis to Investigate Infection, Pathogenesis, Immunity, and Therapeutics

  2022cites this paper
• Murine macrophages do not support the proliferation of Leishmania (Viannia) braziliensis amastigotes even in absence of nitric oxide and presence of high arginase activity

  2022cites this paper
• DEVELOPMENT OF TOPICAL MILTEFOSINE FORMULATIONS FOR THE TREATMENT OF CUTANEOUS LEISHMANIASIS

  2021cites this paper
• Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis

  2021cites this paper
• Long-Term In Vitro Passaging Had a Negligible Effect on Extracellular Vesicles Released by Leishmania amazonensis and Induced Protective Immune Response in BALB/c Mice

  2021cites this paper
• Adjuvanted vaccines driven protection against visceral infection in BALB/c mice by Leishmania donovani.

  2021cites this paper
• Biological assay

  2021cites this paper
• Development of a Fluorescent Assay to Search New Drugs Using Stable tdTomato-Leishmania, and the Selection of Galangin as a Candidate With Anti-Leishmanial Activity

  2021cites this paper
• New Insights into the Mechanism of Action of the Cyclopalladated Complex (CP2) in Leishmania: Calcium Dysregulation, Mitochondrial Dysfunction, and Cell Death

  2021cites this paper
• Immune induction by adjuvanted Leishmania donovani vaccines against the visceral leishmaniasis in BALB/c mice.

  2021cites this paper
• Efficacy of Topical Treatment with (−)-Epigallocatechin Gallate, A Green Tea Catechin, in Mice with Cutaneous Leishmaniasis

  2020cites this paper
• Investigating associations between intestinal alterations and parasite load according to Bifidobacterium spp. and Lactobacillus spp. abundance in the gut microbiota of hamsters infected by Leishmania infantum

  2020cites this paper
• Licochalcone a Exhibits Leishmanicidal Activity in vitro and in Experimental Model of Leishmania (Leishmania) Infantum

  2020cites this paper
• Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Leishmania Inositol Phosphorylceramide Synthase

  2020cites this paper
• Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice

  2020cites this paper
• Efficacy of Photodynamic Therapy Using TiO2 Nanoparticles Doped with Zn and Hypericin Association in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania amazonensis.

  2020cites this paper
• Evaluation of NanoLuc, RedLuc and Luc2 as bioluminescent reporters in a cutaneous leishmaniasis model.

  2020cites this paper
• Single-dose treatment for cutaneous leishmaniasis with an easily synthesized chalcone entrapped in polymeric microparticles

  2020cites this paper
• N, N', N″-trisubstituted guanidines: Synthesis, characterization and evaluation of their leishmanicidal activity.

  2019cites this paper
• Mapping Alterations Induced by Long-Term Axenic Cultivation of Leishmania amazonensis Promastigotes With a Multiplatform Metabolomic Fingerprint Approach

  2019cites this paper
• Ascorbate-Dependent Peroxidase (APX) from Leishmania amazonensis Is a Reactive Oxygen Species-Induced Essential Enzyme That Regulates Virulence

  2019cites this paper
• Novel and safe single-dose treatment of cutaneous leishmaniasis with implantable amphotericin B-loaded microparticles

  2019cites this paper
• Experimental Cutaneous Leishmaniasis: Mouse Models for Resolution of Inflammation Versus Chronicity of Disease.

  2019cites this paper
• Broad Spectrum and Safety of Oral Treatment with a Promising Nitrosylated Chalcone in Murine Leishmaniasis

  2018cites this paper
• Evaluation of Experimental Infection with L. (L.) Amazonensis in X-Linked Immunodeficient Mice

  2018cites this paper
• SODB1 is essential for Leishmania major infection of macrophages and pathogenesis in mice

  2018cites this paper
• The growth and infectivity of Leishmania major is not altered by in vitro exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin

  2018cites this paper
• Extracellular Vesicles Released by Leishmania (Leishmania) amazonensis Promote Disease Progression and Induce the Production of Different Cytokines in Macrophages and B-1 Cells

  2018cites this paper
• Leishmanicidal and Immunomodulatory Activities of the Palladacycle Complex DPPE 1.1, a Potential Candidate for Treatment of Cutaneous Leishmaniasis

  2018cites this paper
• Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection

  2018cites this paper
• A new chimeric triple reporter fusion protein as a tool for in vitro and in vivo multimodal imaging to monitor the development of African trypanosomes and Leishmania parasites.

  2018cites this paper
• Genomic Analysis of Colombian Leishmania panamensis strains with different level of virulence

  2018cites this paper
• Leishmania (Viannia) braziliensis Inositol Phosphorylceramide: Distinctive Sphingoid Base Composition

  2017influential citation
• In vivo antileishmanial activity and histopathological evaluation in Leishmania infantum infected hamsters after treatment with a furoxan derivative.

  2017cites this paper
• Treatment of Leishmania (Leishmania) Amazonensis-Infected Mice with a Combination of a Palladacycle Complex and Heat-Killed Propionibacterium acnes Triggers Protective Cellular Immune Responses

  2017influential citation
• Characterization of the Protein Tyrosine Phosphatase LmPRL-1 Secreted by Leishmania major via the Exosome Pathway

  2017cites this paper
• Anti-parasitic effect of the diuretic and Na+-ATPAse inhibitor furosemide in cutaneous leishmaniasis

  2017cites this paper
• Immunization against full-length protein and peptides from the Lutzomyia longipalpis sand fly salivary component maxadilan protects against Leishmania major infection in a murine model

  2017cites this paper
• Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis

  2017cites this paper
• Leishmania HASP and SHERP Genes Are Required for In Vivo Differentiation, Parasite Transmission and Virulence Attenuation in the Host

  2017cites this paper
• Chemotherapy of leishmaniasis: present challenges

  2017cites this paper
• Lipid-core nanocapsules increase the oral efficacy of quercetin in cutaneous leishmaniasis

  2017cites this paper
• Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.

  2016cites this paper
• Curso de Pós-Graduação em Biotecnologia em Saúde e Medicina Investigativa

  2016cites this paper
• Leishmania amazonensis Engages CD36 to Drive Parasitophorous Vacuole Maturation

  2016cites this paper
• Cysteine Peptidase B Regulates Leishmania mexicana Virulence through the Modulation of GP63 Expression

  2016cites this paper
• Concomitant Immunity Induced by Persistent Leishmania major Does Not Preclude Secondary Re-Infection: Implications for Genetic Exchange, Diversity and Vaccination

  2016cites this paper
• Distinct courses of infection with Leishmania (L.) amazonensis are observed in BALB/c, BALB/c nude and C57BL/6 mice

  2016cites this paper
• Leishmania (Viannia) braziliensis amastigotes from patients with mucosal leishmaniasis have increased ability to disseminate and are controlled by nitric oxide at the early stage of murine infection.

  2016cites this paper
• EFFECTS OF TREATMENT WITH CHITIN MICRO-PARTICLES ON LEISHMANIA MAJOR BURDEN IN BALB/C MICE BY USING TITRATION METHOD

  2015cites this paper
• Enhancement of experimental cutaneous leishmaniasis by Leishmania extract: identification of a disease-associated antibody specificity

  2015cites this paper
• IL-27 enhances Leishmania amazonensis infection via ds-RNA dependent kinase (PKR) and IL-10 signaling.

  2015cites this paper
• Immunomodulatory effects of chitin microparticles on Leishmania major-infected BALB/c mice.

  2015cites this paper
• B-1 cells contribute to susceptibility in experimental infection with Leishmania (Leishmania) chagasi

  2015cites this paper
• Comparison of Parasite Burden Using Real-Time Polymerase Chain Reaction Assay and Limiting Dilution Assay in Leishmania major Infected Mouse

  2015cites this paper
• Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis.

  2015cites this paper
• In vitro and in vivo evaluation of quinones from Auxemma oncocalyx Taub. on Leishmania braziliensis

  2015cites this paper
• Cinnamic Acid Bornyl Ester Derivatives from Valeriana wallichii Exhibit Antileishmanial In Vivo Activity in Leishmania major-Infected BALB/c Mice

  2015cites this paper
• Drug Delivery by Tattooing to Treat Cutaneous Leishmaniasis

  2014cites this paper
• Effectiveness of miltefosine-pentoxifylline compared to miltefosine in the treatment of cutaneous leishmaniasis in C57Bl/6 mice.

  2014cites this paper
• Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally

  2014cites this paper
• Regulation of immunity to visceral Leishmania in a non-human primate model of infection

  2014cites this paper
• Lundep, a Sand Fly Salivary Endonuclease Increases Leishmania Parasite Survival in Neutrophils and Inhibits XIIa Contact Activation in Human Plasma

  2014cites this paper
• In Vitro and In Vivo Miltefosine Susceptibility of a Leishmania amazonensis Isolate from a Patient with Diffuse Cutaneous Leishmaniasis

  2014cites this paper
• Desenvolvimento de estratégias alternativas para teste de fármacos: obtenção e caracterização de linhagens mutantes estáveis de Leishmania expressando luciferase

  2014cites this paper
• Immunostimulatory responses to crude extracts of Warburgia ugandensis (sprague) subsp ugandensis (canellaceae) by Balb/c mice infected with Leishmania major

  2014influential citation
• 2,3,7,8-Tetrachlorodibenzo-p-dioxin Slows the Progression of Experimental Cutaneous Leishmaniasis in Susceptible BALB/c and SCID Mice

  2013cites this paper
• Impact of Neutrophil-Secreted Myeloid Related Proteins 8 and 14 (MRP 8/14) on Leishmaniasis Progression

  2013cites this paper
• Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool.

  2013cites this paper
• The Leishmania major BBSome subunit BBS1 is essential for parasite virulence in the mammalian host

  2013cites this paper
• Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.

  2012cites this paper
• Leishmaniasis: prevention, parasite detection and treatment.

  2012cites this paper
• In Vitro and In Vivo Activity of a Palladacycle Complex on Leishmania (Leishmania) amazonensis

  2012cites this paper
• [A case of feline leishmaniasis in the south of France].

  2012cites this paper
• One-year clinical and parasitological follow-up of dogs treated with marbofloxacin for canine leishmaniosis.

  2012cites this paper
• Dendritic Cell-Mediated Vaccination Relies on Interleukin-4 Receptor Signaling to Avoid Tissue Damage after Leishmania major Infection of BALB/c Mice

  2012cites this paper
• Un cas de leishmaniose féline disséminée dans le sud de la France

  2012cites this paper
• In Vitro and In Vivo Activity of an Organic Tellurium Compound on Leishmania (Leishmania) chagasi

  2012cites this paper
• Appraisal of a Leishmania major Strain Stably Expressing mCherry Fluorescent Protein for Both In Vitro and In Vivo Studies of Potential Drugs and Vaccine against Cutaneous Leishmaniasis

  2012cites this paper
• Structure and Function of a “Yellow” Protein from Saliva of the Sand Fly Lutzomyia longipalpis That Confers Protective Immunity against Leishmania major Infection*

  2011cites this paper
• Preparation of highly infective Leishmania promastigotes by cultivation on SNB-9 biphasic medium.

  2011influential citation
• Immune and inflammatory responses to Leishmania amazonensis isolated from different clinical forms of human leishmaniasis in CBA mice.

  2011cites this paper
• Methods for Leishmania parasite detection and quantification as a tool for study of the pathogen-vector-host interactions Summary of the PhD thesis

  2011cites this paper
• Diagnosis and therapy of cutaneous and mucocutaneous Leishmaniasis in Germany

  2011cites this paper
• DNA vaccination with KMP11 and Lutzomyia longipalpis salivary protein protects hamsters against visceral leishmaniasis.

  2011cites this paper
• Leishmania persistence and host cell interactions

  2011cites this paper